Rankings
▼
Calendar
AKTS FY 2022 Earnings — Aktis Oncology, Inc. Revenue & Financial Results | Market Cap Arena
AKTS
Aktis Oncology, Inc.
$1B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$20M
Net Income
-$18M
EPS (Diluted)
$0.00
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$20M
Stock-Based Comp.
$698,000
Balance Sheet
Total Assets
$138M
Total Liabilities
$158M
Stockholders' Equity
-$19M
Cash & Equivalents
$129M
← FY 2023
All Quarters